{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:40:06Z","timestamp":1793979606760,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFH0045"],"award-info":[{"award-number":["2022YFH0045"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFH0102"],"award-info":[{"award-number":["2022YFH0102"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32222046"],"award-info":[{"award-number":["32222046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170844"],"award-info":[{"award-number":["82170844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172630"],"award-info":[{"award-number":["82172630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270613"],"award-info":[{"award-number":["82270613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21022"],"award-info":[{"award-number":["ZYJC21022"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.apsb.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:40:45Z","timestamp":1692416445000},"page":"854-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Yunzhu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-798X","authenticated-orcid":false,"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8007-0000","authenticated-orcid":false,"given":"Shi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-8931","authenticated-orcid":false,"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-6262","authenticated-orcid":false,"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2023.08.014_bib1","first-page":"284","article-title":"Ovarian cancer statistics","volume":"68","author":"Torre","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.apsb.2023.08.014_bib2","first-page":"409","article-title":"Cancer treatment and survivorship statistics","volume":"72","author":"Miller","year":"2022","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.apsb.2023.08.014_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.apsb.2023.08.014_bib4","first-page":"371","article-title":"Treatment of epithelial ovarian cancer","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2023.08.014_bib5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMe2116353","article-title":"Recurrent ovarian cancer\u2014sculpting a promising future with surgery","volume":"385","author":"Gardner","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2023.08.014_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158800","article-title":"Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer","volume":"132","author":"Chen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2023.08.014_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41577-022-00719-y","article-title":"Tumour immunotherapy: lessons from predator-prey theory","volume":"22","author":"Hamilton","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2023.08.014_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2023.08.014_bib9","first-page":"300","article-title":"Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy","volume":"17","author":"Han","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2023.08.014_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.nano.2017.04.006","article-title":"Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer","volume":"13","author":"Liu","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2023.08.014_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","article-title":"Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells","volume":"184","author":"Glassman","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2023.08.014_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","article-title":"Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours","author":"Mansurov","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2023.08.014_bib13","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-17-0483","article-title":"Combination therapy with NHS-muIL12 and avelumab (anti-PD-L1) enhances antitumor efficacy in preclinical cancer models","volume":"23","author":"Xu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2023.08.014_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/cimm.1994.1192","article-title":"Cooperation of natural killer cell stimulatory factor\/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells","volume":"156","author":"Asteamezaga","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.apsb.2023.08.014_bib15","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","article-title":"Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis","volume":"184","author":"Kaczanowska","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2023.08.014_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/87.8.581","article-title":"Inhibition of angiogenesis in\u00a0vivo by interleukin 12","volume":"87","author":"Voest","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2023.08.014_bib17","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"Del Vecchio","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2023.08.014_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41551-022-00888-0","article-title":"Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker","volume":"6","author":"Mansurov","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2023.08.014_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi6899","article-title":"A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors","volume":"7","author":"Xue","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2023.08.014_bib20","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1021\/acsnano.0c03109","article-title":"Cancer cell coating nanoparticles for optimal tumor-specific cytokine delivery","volume":"14","author":"Barberio","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2023.08.014_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10453","article-title":"Layer-by-layer interleukin-12 nanoparticles drive a safe and effective response in ovarian tumors","volume":"8","author":"Barberio","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.apsb.2023.08.014_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ccell.2021.08.005","article-title":"Activating a collaborative innate-adaptive immune response to control metastasis","volume":"39","author":"Sun","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2023.08.014_bib23","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2023.08.014_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1471-4906(00)01824-X","article-title":"IL-12 gene therapy for cancer: in synergy with other immunotherapies","volume":"22","author":"Melero","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2023.08.014_bib25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","article-title":"Ovarian cancer mutational processes drive site-specific immune evasion","volume":"612","author":"Vazquez-Garcia","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2023.08.014_bib26","first-page":"21","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","author":"Yi","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2023.08.014_bib27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.apsb.2022.08.006","article-title":"Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell- mediated cytotoxicity mediating PD-L1highCD11bD cells elimination in hepatocellular carcinoma","volume":"13","author":"Tan","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.08.014_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-022-01242-2","article-title":"Improvement of the anticancer efficacy of PD-1\/PD-L1 blockade via combination therapy and PD-L1 regulation","volume":"15","author":"Wu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2023.08.014_bib29","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/0008-5472.CAN-16-0258","article-title":"Tumor-Intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma","volume":"76","author":"Clark","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2023.08.014_bib30","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.08.014_bib31","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/cr500131f","article-title":"Biodegradable polymer nanogels for drug\/nucleic acid delivery","volume":"115","author":"Li","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2023.08.014_bib32","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.apsb.2023.08.014_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-023-35957-8","article-title":"Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2023.08.014_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2023.08.014_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer Immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2023.08.014_bib36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1039\/C7SC04004K","article-title":"Advances in targeting the folate receptor in the treatment\/imaging of cancers","volume":"9","author":"Fernandez","year":"2018","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2023.08.014_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor alpha in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2023.08.014_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2020.04.010","article-title":"Delivery of CRISPR\/Cas systems for cancer gene therapy and immunotherapy","volume":"168","author":"Song","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2023.08.014_bib39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.apsb.2020.01.006","article-title":"Interfacial properties and micellization of triblock poly(ethylene glycol)-poly(epsilon-caprolactone)-polyethyleneimine copolymers","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.08.014_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2023.08.014_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108189","article-title":"Novel strategies exploiting interleukin-12 in cancer immunotherapy","volume":"239","author":"Cirella","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2023.08.014_bib42","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1158\/1078-0432.CCR-14-2085","article-title":"Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma","volume":"21","author":"Zhang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2023.08.014_bib43","doi-asserted-by":"crossref","first-page":"e2100137","DOI":"10.1002\/adma.202100137","article-title":"Tumor-associated macrophage and tumor-cell dually transfecting polyplexes for efficient interleukin-12 cancer gene therapy","volume":"33","author":"Qiu","year":"2021","journal-title":"Adv Mat"},{"key":"10.1016\/j.apsb.2023.08.014_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.apsb.2015.03.001","article-title":"Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment","volume":"5","author":"Kang","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.08.014_bib45","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1200\/JCO.22.01900","article-title":"Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: results from the SORAYA study","volume":"41","author":"Matulonis","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2023.08.014_bib46","doi-asserted-by":"crossref","first-page":"OF3","DOI":"10.1158\/2159-8290.CD-NB2021-0361","article-title":"\"Significant activity\" for ADC in ovarian cancer","volume":"11","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2023.08.014_bib47","article-title":"Simultaneous delivery of immune stimulatory gene and checkpoint blocker via targeted nanoparticles to strengthen antitumor immunity","volume":"17","author":"Hu","year":"2022","journal-title":"Mat Today Nano"},{"key":"10.1016\/j.apsb.2023.08.014_bib48","article-title":"A metabolic reprogramming amino acid polymer as an immunosurveillance activator and leukemia targeting drug carrier for T-cell acute lymphoblastic leukemia","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2023.08.014_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Wojno","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2023.08.014_bib50","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41423-022-00925-7","article-title":"Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis","volume":"19","author":"Shan","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2023.08.014_bib51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.apsb.2023.08.014_bib52","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.173.4.869","article-title":"Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers","volume":"173","author":"Chan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2023.08.014_bib53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.170.3.827","article-title":"Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes","volume":"170","author":"Kobayashi","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2023.08.014_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat Rev Drug Discov"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523003180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523003180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:04:48Z","timestamp":1761930288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383523003180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2211383523003180"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2023.08.014","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}